(CYTK:Consolidated Issue listed on NASDAQ Capital Market)
John C. Chabala Ph.D.
Member Scientific Advisory Board, Cytokinetics, Incorporated
|Age||Total Calculated Compensation||This person is connected to 62 board members in 6 different organizations across 6 different industries.|
See Board Relationships
Dr. John C. Chabala, also known as Jack, Ph.D. is a Scientific Advisor of Boston Millennia Partners. Dr. Chabala serves as a Member of the Management Scientific Advisory Board of Pharmacopeia, Inc. and Member Scientific Advisory Board at Cytokinetics Incorporated, Mpex Pharmaceuticals, Inc., NexGenix Pharmaceuticals Holdings, Inc., and Clear Therapeutics, Inc. He serves on the Scientific Advisory Boards of, and as an independent Consultant to, early stage drug discovery ...
280 East Grand AvenuePhone: 650-624-3000
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Paolo Pucci||Chief Executive Officer and Director|
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee|
CTI BioPharma Corp.
|Ali Fattaey Ph.D.||Chief Executive Officer, President and Director|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Werner Lanthaler MBA,MPA||Chief Executive Officer and Member of Management Board|
|€601.0K||Compensation as of Fiscal Year 2013.|